A novel angiogenesis inhibitor impairs lovo cell survival via targeting against human VEGFR and its signaling pathway of phosphorylation

Colorectal cancer represents the fourth commonest malignancy, and constitutes a major cause of significant morbidity and mortality among other diseases. However, the chemical therapy is still under development. Angiogenesis plays an important role in colon cancer development. We developed HMQ18–22 (...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Y M, Dai, B L, Zheng, L, Zhan, Y Z, Zhang, J, Smith, W W, Wang, X L, Chen, Y N, He, L C
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group 2012
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3481133/
https://www.ncbi.nlm.nih.gov/pubmed/23059825
http://dx.doi.org/10.1038/cddis.2012.145

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3481133/
https://www.ncbi.nlm.nih.gov/pubmed/23059825
http://dx.doi.org/10.1038/cddis.2012.145

Ejemplares similares